Moritz studied Molecular Biotechnology at the Technische Universität München (TUM). After the Bachelor’s degree (thesis on the synthesis and interactions of a transmembrane peptide implicated in Alzheimer’s Disease) he worked on GPCR activation with the NIH/NIDDK. His MSc studies at TUM emphasized molecular medicine, protein biochemistry and –engineering and medicinal microbiology. In his MSc thesis, performed at the Novartis Institutes for Biomedical Research in Basel, CH, Moritz worked on the biochemistry of the COP9 Signalosome complex. He joined Matthias Gstaiger’s group in Ruedi Aebersold’s lab in January 2013 as a PhD student applying affinity purification (AP)-MS and variations thereof to assess proteome modularity and dynamics in growth signaling and viral infection.
1. Hoelsch, K., Sührer, I., Heusel, M. & Weuster-Botz, D. Engineering of formate dehydrogenase: synergistic effect of mutations affecting cofactor specificity and chemical stability. Applied microbiology and biotechnology (2012).
2. McMillin, S. M., Heusel, M., Liu, T., Costanzi, S. & Wess, J. Structural basis of M3 muscarinic receptor dimer/oligomer formation. The Journal of biological chemistry 286, 28584–98 (2011).